NORTH CHICAGO, Ill., Aug. 12, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced a $195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic active ...
The track by which API manufacturing processes are prepared for commercial use is comparable to overlapping integrative process evaluations at commercial scale. This ensures the process is ...
NORTH CHICAGO, Ill., Sept. 29, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the start of construction of its new active pharmaceutical ingredient (API) manufacturing plant in North Chicago ...
SUNNYVALE, Calif., Jan. 31, 2024 /PRNewswire/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of ...
DUBLIN--(BUSINESS WIRE)--The "Active Pharmaceutical Ingredients (APIs) Market - Global Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering. The global active ...
Recently rebranded Actylis is stepping up its drug ingredients game. The raw materials manufacturer—which debuted last fall after chemical supply veteran Aceto wedded its business with 10 other ...
The MarketWatch News Department was not involved in the creation of this content. WESTFORD, Mass., July 15, 2024 /PRNewswire/ -- According to SkyQuest, the global Active Pharmaceutical Ingredients ...
Dublin, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The "United States Active Pharmaceutical Ingredients (APIs) Market - Growth, Trends & Forecast 2025-2033" report has been added to ResearchAndMarkets.com's ...
New state-of-the-art active pharmaceutical ingredient (API) facility will manufacture immunology, oncology and neuroscience medicines Facility expected to be fully operational and serving patients by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback